Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

08.12.2020 | case report | Ausgabe 7-8/2021 Open Access

Wiener klinische Wochenschrift 7-8/2021

COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease

Wiener klinische Wochenschrift > Ausgabe 7-8/2021
M.D. Michael Eder, M.D. Robert Strassl, M.D. Johannes Kläger, M.D. Christof Aigner, M.D. Florian Thalhammer, M.D. Assoc. Prof. PD Dr. Željko Kikić
Wichtige Hinweise
The findings presented in this article have not been published previously in whole or part, except in abstract format.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 7-8/2021

Wiener klinische Wochenschrift 7-8/2021 Zur Ausgabe